Cowen Pounds the Table on Horizon Therapeutics (HZNP), Says Add to Positions Before Earnings
Tweet Send to a Friend
Cowen analyst Ken Cacciatore reiterated an Outperform rating and $120.00 price target on Horizon Therapeutics (NASDAQ: HZNP) expecting the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
